Analgesics for Lower Back Pain
Article information
J Korean Med Assoc. 2006;49(8):665-673
Publication date (electronic) : 2006 August 31
doi :
https://doi.org/10.5124/jkma.2006.49.8.665
Abstract
Lower back pain is one of the major health problems in the general population. The causes of lower back pain are heterogeneous and its treatment is complicated. The administration of oral analgesics is the basic step in the treatment of acute somatic pain. Most physicians advocate the three step analgesic ladder method, and NSAIDs are a mainstay of therapy for both acute and chronic lower back pain. Among the patients with chronic pain narcotics with psychotropic drugs have a better efficacy especially in the patients with neuropathic pain. Successful long-term analgesia is a challenge for physicians. The administration of a single agent or a combination of the above drugs to the specifically individualized patients could improve the function and quality of life and achieve the last goal of treatment of chronic lower back pain.
Keywords: Analgesics; NSAIDs; Narcotics; Psychotropics; Lower back pain
References
1. Long DM, BenDebba M, Torgerson WS, Boyd RJ, Dawson EG, Watts C, et al. Persistent back pain and sciatica in the United States: patient characteristics. J Spinal Disord 1996. 940–58.
2. Roberts LJ, Morrow JD. In : Hardman JG, Limbird LE, eds. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. The pharmacological basis of therapeutics 2001. 10th edth ed. New York: McGraw-Hill; 687–732.
3. Savage R. Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly? Drugs Aging 2005. 22185–200.
4. Nielsen OH, Ainsworth M, Csillag C, Rask-Madsen J. Systematic review: coxibs, nonsteroidal anti-inflammatory drugs or no cyclooxygenase inhibitors in gastroenterological high-risk patients? Aliment Pharmacol Ther 2006. 2327–33.
5. Preston MR, Walter MF, McNulty HP, Lockwood SF, Byun J, Jacob RF, et al. Rofecoxib increases susceptibility of human LDL and membrane lipids to oxidative damage: a mechanism of cardiotoxicity. J Cardiovasc Pharmacol 2006. 47Suppl 1. S7–S14.
6. Walt RP. Misoprostol for the treatment of peptic ulcer and antiinflammatory- drug-induced gastroduodenal ulceration. N Engl J Med 1992. 3271575–1580.
7. Kuffner EK, Dart RC, Bogdan GM, Hill RE, Casper E, Darton L. Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double blind, placebo-controlled trial. Arch Intern Med 2001. 1612247–2252.
8. Malonne H, Coffiner M, Fontaine D, Sonet B, Sereno A, Vanderbist F, et al. Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain. J Clin Pharm Ther 2005. 30113–120.
9. Raffa R. Pharmacologic aspects of successful long-term analgesia. Clin Rheumatol 2006. 25Suppl 1. S9–S15.
10. Peloso PM, Fortin L, Beaulieu A, Kamin M, Rosenthal N. Analgesic efficacy and safty of tramadol/acetaminophen combination tablets (Ultracet) in treatment of chronic lowback pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial. J Rheumatol 2004. 312454–2463.
11. Langford RM. Pain management today-what have we learned? Clin Rheumatol 2006. 25Suppl 1. S2–S8.
12. Jones D, Story DA. Serotonin syndrome and the anesthetist. Anaesth Intensive Care 2005. 33181–187.
13. Ballantyne JC, Mao J. Opioid therapy for Chronic Pain. N Engl J Med 2003. 3491943–1953.
14. Mahowald ML, Singh JA, Majeski P. Opioid use by patients in an orthopedics spine clinic. Arthritis Rheum 2005. 526–10.
15. Furian AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006. 1741589–1594.
16. Eisenberg E, McNicol ED, Carr DB. Efficacy of Systemic review of randomized controlled trials. Eur J Pain 2006. Epub ahead of print.
17. Mystakidou K, Parpa E, Tsilika E, Marvromati A, Smyrniotis V, Vlahos L, et al. Long-term management of noncancer pain with transdermal therapeutic system-fentanyl. J Pain 2003. 4298–306.
18. Kerns JW, White A, Nashelsky J, Sherman S. Does psychiatric treatment help patients with intractable chronic pain? J Fam Pract 2006. 55235–236.
19. Staiger TO, Gaster B, Sullivan MD, Deyo RA. Systematic review of antidepressants in the treatment of chronic low back pain. Spine 2003. 282540–2545.
20. Baron R, Binder A. How neuropathic is sciatica? The mixed pain concept. Orthopade 2004. 33568–567.
21. Maizels M, McCarberg B. Antidepressants and antiepileptic drugs for chronic non-cancer pain. Am Fam Physician 2005. 71483–490.
22. Jackson JL, Browning R. Impact of national low back pain guidlines on clinical practice. South Med J 2005. 98139–143.
23. Toth PP, Urtis J. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone. Clin Ther 2004. 261355–1367.
24. Beebe FA, Barkin RL, Barkin S. A clinical and pharmacologic review of skeletal muscle relaxants for musculoskeletal conditions. Am J Ther 2005. 12151–171.
Article information Continued
Copyright © 2006 Korean Medical Association
